Abiopharma

News list

Lin Yu-Hsin 🟢 acquired 207.0K shares (1 derivative) of BELITE BIO, INC (BLTE) at $0.44 Transaction Date: Mar 31, 2026 | Filing ID: 140137

Full text

News bot April 2, 2026, 8:15 p.m.
🔍 Lin Yu-Hsin (Executive)

Company: BELITE BIO, INC (BLTE)

Report Date: 2026-03-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 206,954
Detailed Transactions and Holdings:
- Acquired 206,954 shares of Stock Option (right to buy) at $0.4386 per share (Derivative)
  Date: 2026-03-31 | Code: A | Expires: 2030-12-22 | Exercise: 2026-03-31 | equity_swap_involved: false | shares_owned_after: 413,908.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: On December 23, 2020, the reporting person was granted an option which shall vest in installments upon satisfaction of certain performance criteria. 206,954 ordinary shares subject to the option that had previously vested remain exercisable. One of the performance criteria was met on 3/31/2026, resulting in vesting of the option as to additional 206,954 ordinary shares.